|
Active substance |
Idebenone |
|
Holder |
Santhera Pharmaceutical Limited |
|
Status |
closed |
|
Indication |
For the treatment of yung patients with Duchenne Muscular Dystrophy who are not taking contamitant glucocorticoid steroids |
|
Public documents |
|
|
Last update |
01/07/2016 |
Raxone®
Last updated on 13/09/2024